Adipocyte differentiation-related protein (ADRP/ADFP) is associated with the globule surface membrane material. Adipophilin (also known as PLIN2) has been shown to detect the expression of ADFP in sebocytes and sebaceous lesions (1-4). Sebaceous carcinoma is a relatively uncommon cutaneous malignancy which can mimic other malignant neoplasms, such as basal and squamous cell carcinomas, as well as benign processes, such as chalazions and blepharitis, resulting in delayed diagnosis and suboptimal treatment (2). It has been reported that adipophilin was expressed in 16 of 16 (100%) sebaceous adenomas with a specific pattern of membranous staining with strong uptake at the periphery of intracytoplasmic lipid vacuoles. Of 25 sebaceous carcinomas, 23 (92%) were also labeled with a similar pattern (2). Additionally, in cases of poorly differentiated sebaceous carcinoma in which sebaceous differentiation could not have been reliably interpreted in H&E sections, adipophilin highlighted sebocytes and xanthelasmas (2). Metastatic renal cell carcinomas were also stained weakly to moderately positive for adipophilin (2). Adipophilin may be a useful marker in the identification of intracytoplasmic lipids, as seen in sebaceous lesions. It is especially helpful in identifying intracytoplasmic lipid vesicles in poorly differentiated sebaceous carcinomas in challenging cases such as small periocular biopsy specimens (2,3). In addition, adipophilin has also been associated with lipid metabolism in Burkitt lymphoma and showed strong expression in the majority of Burkitt lymphomas (4). Adipophilin was also shown to be upregulated in lung adenocarcinoma and therefore may serve as a prospective marker for lung adenocarcinoma (5).